✦ LIBER ✦

A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer

✍ Scribed by Oh, S C; Sur, H Y; Sung, H J; Choi, I K; Park, S S; Seo, J H; Jeen, Y T; Chun, H J; Shin, S W; Mok, Y J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine plus ge

✍ Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB

A multicenter phase II study of biweekly

✍ Chao, Yee; Hsieh, Jan-Sing; Yeh, Hsien-Tang; Su, Yu-Chieh; Wu, Cheng-Chung; Chen 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 291 KB

6576 Irinotecan and low-dose capecitabin

✍ Farhat, F.; Kattan, J.; Chahine, G.; Naser, F.; Youness, F.; Ghosn, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Results of a Phase II Trial of Cetuximab

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

Gastric carcinoma: a phase II study of c

✍ W. Koizumi; S. Ujiie; T. Taguchi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A phase II study of irinotecan and docet

✍ Sun Jin Sym; Heung Moon Chang; Hye Jin Kang; Sung Sook Lee; Min-Hee Ryu; Jae-Lyu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB